Immunoclassification of Psoriasis: a Strategy for Precision Medicine

Conditions:   Immunoclassification;   Psoriasis Intervention:   Biological: adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials